New approaches to immunotoxicity testing are reviewed and discussed. A method of activating T-cells in vivo is presented which circumvents artifacts due to viability effects encountered with in vitro mitogen assays. The use of adoptive transfer approaches to combine the advantages of in vitro manipulation with in vivo function assays is discussed relative to natural killer cells. The need for an in vitro metabolic activation step coupled to other in vitro immunologic assays is discussed.
Introduction
Previous papers have demonstrated the importance of the immune system with regard to the well-being of all animals. It has also been clearly demonstrated that chemicals can modify the immune response, some for the benefit of the animal, e.g., immunopharmaceuticals, and some in potentially harmful ways, e.g., chemical wastes and environmental pollutants. Adequate coverage of the new approaches to immunotoxicity testing would require a separate symposium. The volume of new methods being applied to all sorts of immunologic investigations is enormous, and the list of literature reports increases monthly. Thousands of compounds and their effects on the immune system require examination, and rapid, economical screening procedures would certainly benefit industry as well as health and regulatory agencies.
General Approaches to Testing for Immunotoxicity (1) with low toxicity to the mouse and with the added advantage of a broad plateau of activation rather a a -X than the sharp dose-related peaks commonly seen with the lectin mitogens concanavalin A or phytohaemmagglutinin (2) . SEA was shown to be an in vivo T-cell activator (3). The only in vitro culture required was a 4-hr period for 3H-thymidine uptake (Fig. lb) . Thus, chemical and activator could be present simultaneously in vivo. During these studies, we noticed that certain agents administered in vivo, such as antithymocyte serum (ATS), which disrupts T-cell membrane integrity, showed a greater suppressive effect on in vitro mitogen responsiveness at far lower doses than were required to suppress in vivo activation of T cells by SEA. These cells were 82-87% pure as determined by fluorescence testing with specific antisera. The total in vitro time for these cell separations was relatively short, probably less than 4 hr. Figure 3 shows how the isolated cell populations from each step of separation were mixed with RL1 or YAC tumor cells and adoptively transferred to appropriate mice. The in vitro manipulated cells were thus returned to an in vivo environment. Table 3 depicts the results of the adoptive transfer conditions. Spleen cells alone, although they contained the NK cells, would not demonstrate protection, probably because of insufficient numbers of NK cells. Not until the Ly 5+ Thy 1-cells were highly enriched could protection be seen, but then it was quite remarkable. Further, lysis of this population by Ly 5 antisera showed that the population carrying this surface antigen was definitely involved in protection from the tumor. Such manipulations are impossible in a totally in vivo situation.
By such separations, NK cells or other desired populations could be isolated in vitro, exposed to chemical treatment to assess direct effects, particularly if in vitro metabolic activation could be carried out, and returned to the natural in vivo environment in a syngeneic host for testing. Likewise, such tests could be done on cells from chemical-pretreated animals. 112
Combining in vitro manipulation with adoptive transfer and in vivo functional analysis is one way in which immunotoxicologic studies might be carried out using currently available methodology and averting possible erroneous conclusions caused by problems associated with in vitro survivability.
New Approaches to Screening for Immunotoxicants
Recently, Kutz et al. (5) have applied the MishellDutton in vitro antibody-forming cell system to screening a large number of environmentally relevant compounds. Many of these chemicals were shown to be immunosuppressive but directly cytotoxic to lymphoid cells in vitro at suppressive levels (Table 4) . These chemicals included the organotins, several heavy metals and polychlorinated biphenyls. Others, shown in Table 5 , were suppressive but not cytotoxic. Most notably, azathioprene was suppressive in vitro at levels easily attained in vivo and with similar suppression kinetics. Thus, some degree of predictability was achieved with this system. Cyclophosphamide also had no effect on this system, owing to the lack of the required microsomal activation of this chemical. The need for an in vitro activation step in this potentially useful procedure is discussed by Tucker (6) . Vos (7) and Boonnan (8) also report on new methods for assessing the effects of chemicals on the adult immune system and the developing immune system, respectively.
Conclusion
Immunology as related to toxicology is an exciting field of research. We are currently learning which methods are applicable to toxicity testing and improving and adapting others to make them suitable. While no one magic test will suffice, it may be possible in the very near future to report the development of more rapid, reliable, economical screening methods for a wide range of immune functions which have predictive value to the whole animal.
